Valamehr Bahram
President and CEO
Valamehr Bahram has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2026. 4 of those filings fall inside the rolling window. Most recent filing: Aug 5, 2026.
On the most recent filing, Valamehr Bahram is listed as President and CEO at FATE THERAPEUTICS INC. Inside the rolling window, Valamehr Bahram reported no open-market purchases and 3 open-market sales totaling $168K in FATE. The largest disclosed transaction in the window is a sale of 43,947 FATE shares on Aug 4, 2026, worth $108K.
Companies traded
Other insiders at FATE
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$168K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Valamehr Bahram made?
Valamehr Bahram has filed 4 SEC Form 4 filings (4 transaction rows) across 1 company since 2026.
Which companies does Valamehr Bahram trade?
Valamehr Bahram has filed SEC Form 4 disclosures for 1 company, including FATE.
When was Valamehr Bahram's most recent SEC Form 4 filing?
Valamehr Bahram's most recent SEC Form 4 filing on Tracefour is dated Aug 5, 2026.
What is Valamehr Bahram's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Valamehr Bahram is listed as President and CEO.
What is Valamehr Bahram's total buy and sell value in the current window?
Inside the rolling retention window, Valamehr Bahram bought $0 and sold $168K based on SEC Form 4 filings.
What was Valamehr Bahram's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 43,947 FATE shares on 2026-08-04, worth $108K, per SEC Form 4 filings.